This compound is an N-nitroso impurity standard specifically used for quality control in the synthesis and analysis of dabigatran etexilate. It is a structurally complex molecule with multiple aromatic rings and polar functional groups, reflecting its role as a reference material in pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2892260-29-4
Dabigatran etexilate mesylate
active pharmaceutical ingredient
Dabigatran etexilate mesylate
active pharmaceutical ingredient
Prazaxa
active pharmaceutical ingredient
Delorazepam
active pharmaceutical ingredient
Apalutamide Di-(2-fluoro-N-methylbenzamide)
active pharmaceutical ingredient impurity
Canertinib dihydrochloride
active pharmaceutical ingredient
알프라졸람
active pharmaceutical ingredient
Ethyl 3-[[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionate
Pharmaceutical intermediate for dabigatran
ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
JPLPQAOOSCQYBH-UHFFFAOYSA-N
CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)N(CC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N=O
—